| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Siegfried Kasper, Johannes Tauscher, Matthäus Willeit, Mara Stamenkovic, Alexander Neumeister, Bernd Küfferle, Christian Barnas, Jürgen Stastny, Nicole Praschak-Rieder, Lukas Pezawas, Martina de Zwaan, Sylvia Quiner, Walter Pirker, Susanne Asenbaum, Ivo Podreka, Thomas Brück. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 3. issue 3. 2003-01-23. PMID:12478878. |
in depression as well as in bulimia, selective serotonin reuptake inhibitors significantly decreased the beta-cit binding potential, however, no significant dose relationship has been obtained in depression. |
2003-01-23 |
2023-08-12 |
human |
| Yali Zhao, Marc Klei. Modulation of the readily releasable pool of transmitter and of excitation-secretion coupling by activity and by serotonin at Aplysia sensorimotor synapses in culture. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 22. issue 24. 2003-01-23. PMID:12486160. |
the rrp was reduced after homosynaptic depression of the epsp by low-frequency stimulation and increased after facilitation of the epsp by application of the endogenous facilitatory transmitter serotonin (5-ht) after homosynaptic depression. |
2003-01-23 |
2023-08-12 |
aplysia |
| Yali Zhao, Marc Klei. Modulation of the readily releasable pool of transmitter and of excitation-secretion coupling by activity and by serotonin at Aplysia sensorimotor synapses in culture. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 22. issue 24. 2003-01-23. PMID:12486160. |
these observations indicate that homosynaptic depression and restoration of depressed transmission by 5-ht are caused by changes in both the amount of transmitter available for immediate release and in processes involved in the coupling of the action potential to transmitter release. |
2003-01-23 |
2023-08-12 |
aplysia |
| Xiao-Fei Gao, Xue-Qi Wang, Cheng He, Chang-Lin L. [Progress of monoaminergic receptor investigation on depression]. Sheng li ke xue jin zhan [Progress in physiology]. vol 33. issue 1. 2003-01-16. PMID:12001723. |
this paper is attempted to review the new progress of investigation into serotonin receptors, adrenoceptors and dopamine receptors related with depression mechanism respectively. |
2003-01-16 |
2023-08-12 |
Not clear |
| Yutaka Masuda, Yusuke Akagawa, Yasuo Hishikaw. Effect of serotonin 1A agonist tandospirone on depression symptoms in senile patients with dementia. Human psychopharmacology. vol 17. issue 4. 2003-01-16. PMID:12404687. |
effect of serotonin 1a agonist tandospirone on depression symptoms in senile patients with dementia. |
2003-01-16 |
2023-08-12 |
Not clear |
| Alan F Schatzber. Pharmacological principles of antidepressant efficacy. Human psychopharmacology. vol 17 Suppl 1. 2003-01-13. PMID:12404665. |
both noradrenaline (na) and serotonin (5-ht) appear to be involved in depression. |
2003-01-13 |
2023-08-12 |
Not clear |
| G Hedo, J A Lopez-Garci. 5-HT(1B) but not 5-HT(6) or 5-HT(7) receptors mediate depression of spinal nociceptive reflexes in vitro. British journal of pharmacology. vol 135. issue 4. 2002-12-26. PMID:11861321. |
5-ht(1b) but not 5-ht(6) or 5-ht(7) receptors mediate depression of spinal nociceptive reflexes in vitro. |
2002-12-26 |
2023-08-12 |
rat |
| G Hedo, J A Lopez-Garci. 5-HT(1B) but not 5-HT(6) or 5-HT(7) receptors mediate depression of spinal nociceptive reflexes in vitro. British journal of pharmacology. vol 135. issue 4. 2002-12-26. PMID:11861321. |
the rank order of potency of agonists for the depression of the cd was 5-carboxamidotryptamine (5-ct)>alpha-methylserotonin (alpha-met-5-ht) approximately 5-ht>42-methylserotonin (2-met-5-ht)approximately 8-oh-dpat. |
2002-12-26 |
2023-08-12 |
rat |
| Yalçin Abdullaev, Barbara L Kennedy, Allan Tasma. Changes in neural circuitry of language before and after treatment of major depression. Human brain mapping. vol 17. issue 3. 2002-12-26. PMID:12391569. |
we measured 128-channel event-related brain potentials (erps) and statistical probability mapping in the use generation task carried out with single visual nouns to explore the topography and time course of these cortical activations related to semantic processing in 11 patients with major unipolar depression before and 8 weeks after treatment with the selective serotonin reuptake inhibitor (ssri) citalopram. |
2002-12-26 |
2023-08-12 |
human |
| M C Austin, R E Whitehead, C L Edgar, J E Janosky, D A Lewi. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience. vol 114. issue 3. 2002-12-20. PMID:12220580. |
the present study used immunocytochemical methods and an antibody against the serotonin transporter to examine the relative density of serotonin axons in the dorsolateral prefrontal cortex of suicide victims with a diagnosis of major depression. |
2002-12-20 |
2023-08-12 |
human |
| Xiaogang Liao, Edgar T Walter. The use of elevated divalent cation solutions to isolate monosynaptic components of sensorimotor connections in Aplysia. Journal of neuroscience methods. vol 120. issue 1. 2002-12-20. PMID:12351206. |
hi-di solutions had no effect on activity-dependent synaptic depression or posttetanic potentiation, or facilitation by serotonin (5-ht). |
2002-12-20 |
2023-08-12 |
aplysia |
| J M Owens, D L Knight, C B Nemerof. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine]. L'Encephale. vol 28. issue 4. 2002-12-19. PMID:12232544. |
single isomers of the selective serotonin reuptake inhibitors citalopram (escitalopram, s-citalopram) and fluoxetine (r-fluoxetine) are currently under development for the treatment of depression and other psychiatric disorders. |
2002-12-19 |
2023-08-12 |
human |
| M E Sewnath, R van Hillegersberg, M M W Koopman, M M Levi, D J Goum. [Increased perioperative blood loss during treatment with paroxetine]. Nederlands tijdschrift voor geneeskunde. vol 146. issue 38. 2002-12-17. PMID:12369443. |
paroxetine is a non-tricyclic serotonin reuptake inhibitor prescribed for the treatment of depression. |
2002-12-17 |
2023-08-12 |
Not clear |
| David J Nut. The neuropharmacology of serotonin and noradrenaline in depression. International clinical psychopharmacology. vol 17 Suppl 1. 2002-12-17. PMID:12369606. |
the neuropharmacology of serotonin and noradrenaline in depression. |
2002-12-17 |
2023-08-12 |
Not clear |
| Bill Deakin, Serdar Dursu. Optimizing antidepressant treatment: efficacy and tolerability. International clinical psychopharmacology. vol 17 Suppl 1. 2002-12-17. PMID:12369607. |
it has been suggested that dual-action antidepressants acting on both serotonin and noradrenaline pathways in the brain may offer superior therapeutic benefit over classical antidepressants, particularly in severe depression. |
2002-12-17 |
2023-08-12 |
Not clear |
| Raphael T W Chan, Joseph M Rey, Philip L Hazel. Clinical practice guidelines for depression in young people: are the treatment recommendations outdated? The Medical journal of Australia. vol 177. issue 8. 2002-12-17. PMID:12381257. |
changes to the guidelines should include the findings that selective serotonin reuptake inhibitors and some forms of psychotherapy are effective in treating adolescent depression. |
2002-12-17 |
2023-08-12 |
Not clear |
| Eric J Hernandez, Philip A Williams, F Edward Dude. Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia. vol 43. issue 11. 2002-12-13. PMID:12423383. |
fluoxetine is a selective serotonin [5-hydroxytryptamine (5-ht)] reuptake inhibitor (ssri) commonly used to treat depression. |
2002-12-13 |
2023-08-12 |
rat |
| M Bourin, D J P David, P Jolliet, A Gardie. [Mechanism of action of antidepressants and therapeutic perspectives]. Therapie. vol 57. issue 4. 2002-12-10. PMID:12422559. |
depression is due to a deficiency in one or other biogenic monoamines (serotonin, 5-ht; noradrenaline, na; dopamine, da). |
2002-12-10 |
2023-08-12 |
Not clear |
| M Bourin, D J P David, P Jolliet, A Gardie. [Mechanism of action of antidepressants and therapeutic perspectives]. Therapie. vol 57. issue 4. 2002-12-10. PMID:12422559. |
developing drugs using innovative mechanisms such as directly acting on 5-ht receptors (5-ht1a agonists or 5-ht2 antagonists), would appear to be useful in the treatment of depression. |
2002-12-10 |
2023-08-12 |
Not clear |
| C Mulert, G Juckel, H Augustin, U Heger. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. vol 113. issue 10. 2002-12-04. PMID:12350432. |
comparison between the analysis of the loudness dependency of the auditory n1/p2 component with loreta and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. |
2002-12-04 |
2023-08-12 |
Not clear |